English
Back
Download
Log in to access Online Inquiry
Back to the Top

High P/S ratio for Shanghai Allist Pharmaceuticals could dis...

High P/S ratio for Shanghai Allist Pharmaceuticals could discourage investors if revenue growth slows. Analysts question sustainability of current P/S ratio, suggesting share price may struggle unless significant industry outperformance.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
4418 Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    4953
    Followers
    0
    Following
    11K
    Visitors
    Follow

    Market Insights

    Market Hot Picks Market Hot Picks
    Unlock Now

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.